# FDA Inspection 1202930 - Russell A. Foulk, MD - March 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/russell-a-foulk-md/104b8cc8-81b4-460b-8e46-dd3544d3ff16
Source feed: FDA_Inspections

> FDA Inspection 1202930 for Russell A. Foulk, MD on March 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202930
- Company Name: Russell A. Foulk, MD
- Inspection Date: 2023-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 696261 - 2010-11-01](https://www.keypedia.com/records/fda_inspections/russell-a-foulk-md/dea591f3-e6fe-4eec-8e0c-de30969fcb66)

Company: https://www.keypedia.com/companies/russell-a-foulk-md/73cb23d0-83da-4bae-b3c5-12a9ab7c0651

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c